Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer
- 1 April 2004
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 93 (1) , 215-222
- https://doi.org/10.1016/j.ygyno.2003.12.031
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 23 references indexed in Scilit:
- Angiopoietin‐2 expression in breast cancer correlates with lymph node invasion and short survivalInternational Journal of Cancer, 2002
- Prognostic significance of ultrasound derived intratumoral peak systolic velocity in epithelial ovarian cancerUltrasound in Obstetrics & Gynecology, 2002
- Expression of Angiopoietin-1, Angiopoietin-2, and Tie2 Genes in Normal Ovary with Corpus luteum and in Ovarian CancerOncology, 2002
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Is Angiopoietin-2 Necessary for the Initiation of Tumor Angiogenesis?The American Journal of Pathology, 1998
- Increased Vascularization in Mice Overexpressing Angiopoietin-1Science, 1998
- Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression CloningCell, 1996
- Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancerThe Lancet, 1992
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971